XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

Note 16 - Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes to Financial Statements |
Stock-Based Compensation | Note 16. Stock-Based Compensation The Company’s Board of Directors adopted in February 2010, and the stockholders approved in May 2010, the QCR Holdings, Inc. 2010 Equity Incentive Plan (“2010 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2013, and the stockholders approved in May 2013, the QCR Holdings, Inc. 2013 Equity Incentive Plan (“2013 Equity Incentive Plan”). The Company’s Board of Directors adopted in February 2016, and the stockholders approved in May 2016, the QCR Holdings, Inc. 2016 Equity Incentive Plan (“2016 Equity Incentive Plan”). Up to 350,000, 350,000, and 400,000 shares of common stock, respectively, may be issued to employees and directors of the Company and its subsidiaries pursuant to equity incentive awards granted under these plans. The 2010 Equity Incentive Plan, the 2013 Equity Incentive Plan and the 2016 Equity Incentive Plan (collectively, the “Equity Plans”) are administered by the Compensation Committee of the Board of Directors (the “Committee”). As of December 31, 2022, there were 100,271 remaining shares of common stock available for the grant of future awards under the Equity Plans; however, such future awards may be granted only under the 2016 Equity Incentive Plan. The number and exercise price of options granted under the Equity Plans are determined by the Committee at the time the option is granted. In no event can the exercise price be less than the value of the common stock at the date of the grant for stock options. All options have a 10-year life and will vest and become exercisable from 3-to-7 years after the date of the grant. The value of restricted stock awards is estimated by using the market price of the Company’s common stock at the date of grant. Note 16. Stock-Based Compensation (continued) Stock-based compensation expense was reflected in the Consolidated Financial Statements as follows for the years ended December 31, 2022, 2021, and 2020. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
​ | ​ | (dollars in thousands)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Stock options | ​ | $ | 246 | ​ | $ | 270 | ​ | $ | 297
Restricted stock awards | ​ | ​ | 1,967 | ​ | ​ | 1,864 | ​ | ​ | 1,619
Stock purchase plan | ​ |  | 225 | ​ |  | 218 | ​ |  | 234
​ | ​ | $ | 2,438 | ​ | $ | 2,352 | ​ | $ | 2,150
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ Stock options: A summary of the stock option plans as of December 31, 2022, 2021, and 2020 and changes during the years then ended is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ | ​ | 2022 | ​ | 2021 | ​ | 2020
​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | Weighted
​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | ​ | Average
​ | ​ | ​ | ​ | ​ | Exercise | ​ | ​ | ​ | ​ | Exercise | ​ | ​ | ​ | ​ | Exercise
​ |  | Shares |  | Price |  | Shares |  | Price |  | Shares |  | Price
Outstanding, beginning | ​ | ​ | 367,998 | ​ | $ | 24.46 | ​ | ​ | 407,763 | ​ | $ | 22.24 | ​ | ​ | 426,913 | ​ | $ | 20.14
Granted |  | ​ | 22,400 | ​ |  | 53.87 |  | ​ | 22,150 | ​ |  | 43.61 |  | ​ | 23,350 | ​ |  | 39.12
Exercised |  | ​ | (41,695) | ​ |  | 14.07 |  | ​ | (60,317) | ​ |  | 15.76 |  | ​ | (41,650) | ​ |  | 10.67
Forfeited |  | ​ | (2,025) | ​ |  | 26.72 |  | ​ | (1,598) | ​ |  | 38.50 |  | ​ | (850) | ​ |  | 19.94
Outstanding, ending |  | ​ | 346,678 | ​ |  | 27.60 |  | ​ | 367,998 | ​ |  | 24.46 |  | ​ | 407,763 | ​ |  | 22.24
​ |  | ​ |  | ​ |  |  |  | ​ |  | ​ |  |  |  | ​ |  | ​ |  |
Exercisable, ending |  | ​ | 295,077 | ​ |  |  |  | ​ | 318,266 | ​ |  |  |  | ​ | 354,899 | ​ |  |
​ |  | ​ |  | ​ |  |  |  | ​ |  | ​ |  |  |  | ​ |  | ​ |  |
Weighted average fair value per option granted | ​ | $ | 13.97 | ​ |  |  | ​ | $ | 10.85 | ​ |  |  | ​ | $ | 10.07 | ​ |  |
​ A further summary of options outstanding as of December 31, 2022 is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options Outstanding | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | Options Exercisable
​ | ​ | ​ | ​ | Average | ​ | Weighted | ​ | ​ | ​ | Weighted
​ | ​ | ​ | ​ | Remaining | ​ | Average | ​ | ​ | ​ | Average
Range of | ​ | Number | ​ | Contractual | ​ | Exercise | ​ | Number | ​ | Exercise
Exercise Prices |  | Outstanding |  | Life |  | Price |  | Exercisable |  | Price
$15.50 to $15.65 | ​ | 57,616 | ​ | 0.25 | ​ | $ | 15.64 | ​ | 57,616 | ​ | $ | 15.64
$17.10 to $18.00 |  | 108,890 |  | 1.57 | ​ |  | 17.32 |  | 108,890 | ​ |  | 17.32
$22.64 to $22.64 |  | 53,316 |  | 3.08 | ​ |  | 22.64 |  | 53,316 | ​ |  | 22.64
$36.00 to $41.95 |  | 36,773 |  | 6.67 | ​ |  | 38.30 |  | 23,060 | ​ |  | 38.06
$42.65 to $48.50 |  | 67,908 |  | 5.63 | ​ |  | 43.76 |  | 51,995 | ​ |  | 43.80
$53.87 to $56.26 |  | 22,175 |  | 9.17 | ​ |  | 53.89 |  | 200 | ​ |  | 53.87
​ |  | 346,678 |  |  | ​ |  |  |  | 295,077 | ​ |  |
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  |
​ Note 16. Stock-Based Compensation (continued) Restricted stock and unit awards: A summary of changes in the Company’s nonvested restricted stock, restricted stock unit and performance stock unit awards as of December 31, 2022, 2021 and 2020 is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2022 |  | 2021 |  | 2020
Outstanding, beginning | ​ | ​ | 97,107 | ​ | ​ | 102,489 | ​ | ​ | 106,826
Granted* | ​ |  | 35,525 | ​ |  | 38,360 | ​ |  | 34,559
Released | ​ |  | (47,766) | ​ |  | (43,691) | ​ |  | (37,296)
Forfeited | ​ |  | (751) | ​ |  | (51) | ​ |  | (1,600)
Outstanding, ending | ​ | ​ | 84,115 | ​ | ​ | 97,107 | ​ | ​ | 102,489
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Weighted average fair value per share granted | ​ | $ | 54.20 | ​ | $ | 45.18 | ​ | $ | 39.39
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ * At December 31, 2022, includes 8,527 shares of restricted stock, 64,494 restricted stock units. At December 31, 2021, includes 12,412 shares of restricted stock and 25,948 restricted stock units. At December 31, 2020, includes 8,913 shares of restricted stock and 25,646 restricted stock units. ​ The total grant value of restricted stock, restricted stock unit and performance share unit awards that were released during the years ended December 31, 2022, 2021 and 2020 was $2.6 million, $1.9 million and $1.4 million, respectively. Employee stock purchase plan: In October 2002, the Company’s Board of Directors and its stockholders adopted the QCR Holdings, Inc. Employee Stock Purchase Plan (the “Prior Purchase Plan”) which was amended and restated on May 2, 2012 and terminated on July 1, 2022. On May 19, 2022, the Company’s stockholders approved the QCR Holdings, Inc. 2022 Stock Purchase Plan (the “2022 Purchase Plan”). The 2022 Purchase Plan has an effective date of July 1, 2022 and a share reserve equal to 350,000 shares plus the shares remaining under the Prior Purchase Plan immediately prior to its termination. As of January 1, 2023, there were 382,765 shares of common stock available for issuance under the Purchase Plan. For each six-month offering period, the Board of Directors will determine how many of the total number of available shares will be offered. The purchase price is the lesser of 85% or the fair market value at the date of the grant or the investment date. The investment date, as established by the Board of Directors, is the date common stock is purchased after the end of each calendar quarter during an offering period. The maximum dollar amount any one participant can elect to contribute in a year is $21,250. Additionally, the maximum percentage that any one participant can elect to contribute is 15% of his or her compensation for the years ended December 31, 2022, 2021 and 2020. Information for the stock purchase plan for the years ended December 31, 2022, 2021 and 2020 is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
Shares granted |  | ​ | 28,421 |  | ​ | 28,396 |  | ​ | 38,738
Shares purchased |  | ​ | 27,103 |  | ​ | 30,543 |  | ​ | 37,114
Weighted average fair value per share granted | ​ | $ | 7.88 | ​ | $ | 7.67 | ​ | $ | 6.03
​

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (l) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration